Moderna personalized mRNA cancer vaccines

What experts have said about Moderna personalized mRNA cancer vaccines

16 statements · 12 positive · 1 negative · 3 neutral

1. Arvelis Bonilla RamosNegativeSep 30, 2026· Stock Movers

   Moderna’s melanoma vaccine success does not broadly validate its platform for other cancers.

   “the melanoma win for the vaccine does not broadly validate the platform for other types of tumors or cancers.”

   Listen at 5:04

   Open the episode · Micron Jumps; Northrop Grumman, Moderna Slide
2. Avalon PurnellPositiveSep 25, 2026· Stock Movers

   Moderna's cancer vaccine could address other markets with higher total addressable markets

   “that it could actually hit other areas that maybe could have a higher TAM”

   Listen at 3:24

   Open the episode · Weekly Roundup: Meta's AI-Driven Rally, Gen Digital Drops, Moderna Surges
3. Avalon PurnellPositiveSep 25, 2026· Stock Movers

   Moderna’s personalized cancer vaccine could address other markets with higher TAM.

   “that it could actually hit other areas that maybe could have a higher TAM”

   Listen at 3:24

   Open the episode · Weekly Roundup: Meta's AI-Driven Rally, Gen Digital Drops, Moderna Surges

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.